Search results
Showing: 10 of 273
MO KTT
Access for:
registered users through ePACT2
public users through Catalyst
The charts and data tables show values for prescribing comparators supporting the quality, innovation, productivity and prevention (QIPP) medicine use and procurement…
Practice detailed prescribing information (PDPI)
Access for registered users via ePACT2.
PDPI provides information on a practice’s prescribing habits and costs. This enables a practice to compare and manage their prescribing performance against national and commissioner or provider comparators.…
Registering for ePACT2
The ePACT2 system is available only to those users who have registered to access.
Prospective users must choose the relevant access required from the selection available below. It is important that users read the information and requirements before…
User guides
Guides to get you started
ePACT2 User Guide - Quick Start (PDF: 740KB)ePACT2 User Guide - Accessing and Using Dashboards and Pre-built Reports (PDF: 2.1MB)
Guides by organisation type
Groups of guides to aid you in getting the most from ePACT2…
ePACT2: Pharmacy First data now available in Analysis Builder tool
On 31 January 2024, the new Pharmacy First - Clinical Pathways (PFCP) Advanced Service was introduced. The service provides advice and NHS funded treatment, where appropriate, for seven common conditions.
PFCP product data (from February 2024 data…
ePACT2: Changes to the Itemised Prescribing Payment (IPP) report – addition of Retro Concession Price Adjustment (line 8)
The IPP financial report has been updated to include a new line:
Line 8 - Retro Concession Price Adjustment:
The Net Ingredient Cost of adjustments caused by the retrospective top-up payment for concessionary prices. Part II Clause 8 E of the…
Medicines optimisation - polypharmacy
The polypharmacy prescribing comparators will help Sub Integrated Care Board Locations (SICBLs) and GP practices understand the variation in prescribing of multiple medicines. They'll also help to identify patients who are more likely to be exposed…
Medicines optimisation - generic prescribing
In England, 81% of all drugs in primary care are already prescribed generically, generating significant savings for the NHS.
Building on what’s been achieved with generic prescribing in recent years, we have developed a dashboard providing rapid…
Safer management of controlled drugs
In order to support the work of controlled drug (CD) accountable officers and SICBLs, a working group has supported us in the development of some CD metrics.
The group have chosen a number of specific areas of prescribing to focus on, based on the…
NHS Clinical Commissioning Group (CCG) reorganisation as of 1 April 2021
The following will be implemented as part of NHS CCG structure changes as of 1 April 2021. The changes will apply to April 2021 dispensing data which will be released mid-June and will be implemented across all our reporting systems where applicable…